Association between Scored Patient-Generated Subjective Global Assessment and Skeletal Muscle Determined by Computed Tomography in Patients with Cervical Cancer

References

• International Agency for Research on Cancer: GLOBOCAN 2018: estimated cancer incidence, and mortality and prevalence worldwide in 2018: cancer fact sheets. IARC, 2018 [Acesso em: 27/01/2019] http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
   Google Scholar
• Instituto Nacional de C âncer José Alencar Gomes da Silva: Estimativa 2018: incidência de Câncer No Brasil/Instituto Nacional de Câncer Jose Alencar Gomes da Silva. Coordenação de Prevenção e Vigilância. Rio de Janeiro: INCA, 2017.
   Google Scholar
• Thuler LC, Aguiar SS, and Bergmann A: Determinantes do diagnóstico em estadio avançado do câncer do colo do útero no Brasil. Rev Bras Ginecol Obstet 36, 237–243, 2014.
   PubMedGoogle Scholar
• Fearon K, Evans WJ, and Anker SD: Myopenia-a new universal term for muscle wasting. J Cachexia Sarcopenia Muscle 2, 1–3, 2011.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, and Bruyère O: Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48, 16–31, 2019.
   PubMed Web of Science ®Google Scholar
• Wolfe RR: The underappreciated role of muscle in health and disease. Am J Clin Nutr 84, 475–482, 2006.
   PubMed Web of Science ®Google Scholar
• Prado CMM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, et al.: Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15, 2920–2926, 2009.
   PubMed Web of Science ®Google Scholar
• Tan BH, Birdsell LA, Martin L, Baracos VE, and Fearon KC: Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15, 6973–6979, 2009.
   PubMed Web of Science ®Google Scholar
• Carneiro IP, Mazurak VC, and Prado CM: Clinical implications of sarcopenic obesity in cancer. Curr Oncol Rep 18, 2016.
   PubMed Web of Science ®Google Scholar
• Rodrigues CS and Chaves GV: Patient-generated Subjective Global Assessment in relation to site, stage of the illness, reason for hospital admission, and mortality in patients with gynecological tumors. Support Care Cancer 23, 871–879, 2015.
   PubMed Web of Science ®Google Scholar
• Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, et al.: Sarcopenia in daily practice: assessment and management. BMC Geriatr 16, 170, 2016.
   PubMed Web of Science ®Google Scholar
• Kiyotoki T, Nakamura K, Haraga J, Omichi C, Ida N, et al.: Sarcopenia is an important prognostic factor in patients with cervical cancer undergoing concurrent chemoradiotherapy. Int J Gynecol Cancer 28, 168–175, 2018.
   PubMed Web of Science ®Google Scholar
• Ottery FD: Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12, S15–S19, 1996.
   PubMed Web of Science ®Google Scholar
• Bauer J, Capra S, and Ferguson M: Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56, 779–785, 2002.
   PubMed Web of Science ®Google Scholar
• World Health Organization: Obesity: preventing and a managing the global epidemic. WHO Technical Report Series 894, 256, 2000.
   Google Scholar
• FIGO Committee on gynecologic oncology: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105, 103–104, 2009.
   PubMed Web of Science ®Google Scholar
• Gonzalez MC, Borges LR, Silveira DH, Assunção MCF, and Orlandi SP: Validação da versão em português da avaliação subjetiva global produzida pelo paciente. Rev Bras Nutr Clin 25, 102–108, 2010.
   Google Scholar
• Ottery FD: Patient-Generated Subjective Global Assessment. In: The Clinical Guide to Oncology Nutrition, McCallum PD and Polisena CG (eds.). Chicago: The American Dietetic Association, 2000, pp. 11–23
   Google Scholar
• Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, and Ross R: Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85, 115–122, 1998.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, and Baracos VE: A practical and precise approach to quantification of body composition in câncer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997–1006, 2008.
   PubMed Web of Science ®Google Scholar
• Das U, Patel S, Dave K, and Bhansali R: Assessment of nutritional status of gynecological cancer cases in India and comparison of subjective and objective nutrition assessment parameters. South Asian J Cancer 3, 38, 2014.
   PubMedGoogle Scholar
• Shachar SS, Williams GR, Muss HB, and Nishijima TF: Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer 57, 58–67, 2016.
   PubMed Web of Science ®Google Scholar
• De Paula NS, Bruno KA, Aredes MA, and Chaves GV: Sarcopenia and skeletal muscle quality as predictors of postoperative complication and early mortality in gynecologic cancer. Int J Gynecol Cancer 28, 412–420, 2017.
   Web of Science ®Google Scholar
• De Paula NS, Rodrigues CS, and Chaves GV: Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer. Eur J Clin Nutr 73, 524–530, 2019.
   PubMed Web of Science ®Google Scholar
• Aredes MA, Garcez MR, and Chaves GV: Influence of chemoradiotherapy on nutritional status, functional capacity, quality of life and toxicity of treatment for patients with cervical cancer. Nutr Diet 75, 263–270, 2018.
   PubMed Web of Science ®Google Scholar
• Chantragawee C, and Achariyapota V: Utilization of a scored patient-generated subjective global assessment in detecting a malnourished status in gynecologic cancer patients. Asian Pac J Cancer Prev 17, 4401–4404, 2016.
   PubMedGoogle Scholar
• Argilés JM: Cancer-associated malnutrition. Eur J Oncol Nurs 9, 39–50, 2005.
   PubMedGoogle Scholar
• Wyke SM, and Tisdale MJ: NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 92, 711–721, 2005.
   PubMed Web of Science ®Google Scholar
• Clark LH, Jackson AL, Soo AE, Orrey DC, Gehrig PA, and Kim KH: Extremes in body mass index affect overall survival in women with cervical cancer. Gynecol Oncol 141, 497–500, 2016.
   PubMed Web of Science ®Google Scholar
• Prado CM, Wells JC, Smith SR, Stephan BC, and Siervo M: Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 31, 583–601, 2012.
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al.: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629–635, 2008.
   PubMed Web of Science ®Google Scholar
• Laky B, Janda M, Cleghorn G, and Obermair A: Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87, 1678–1685, 2008.
   PubMed Web of Science ®Google Scholar
• Saka B, Ozturk GB, Uzun S, Erten N, Genc S, et al.: Nutritional risk in hospitalized patients: impact of nutritional status on serum prealbumin. Rev Nutr 24, 89–98, 2011.
   Web of Science ®Google Scholar
• Gabrielson DK, Scaffidi D, Leung E, Stoyanoff L, Robinson J, et al.: Use of an abridged scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting. Nutr Cancer 65, 234–239, 2013.
   PubMed Web of Science ®Google Scholar
• Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, et al.: International clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging 22, 1148–1161, 2018.]
   PubMed Web of Science ®Google Scholar